-
Belarus' Lukashenko greeted by North Korean leader in Pyongyang
-
Video shows Chiefs star Mahomes making progress in NFL comeback
-
Bayern beat Man Utd in five-goal women's Champions League thriller
-
Wales would be 'massive asset' to World Cup, says Bellamy
-
NFL champion Seahawks to open season on September 9
-
Silver vows NBA tanking solution before draft, seeks Euroleague partnership
-
Day of reckoning arrives for social media after US court loss
-
World Cup concerns are exaggerated, says FIFA vice-president
-
Oil prices slip, stocks rally as Washington, Tehran bicker over talks
-
NBA team owners approve exploring expansion to Seattle and Las Vegas
-
UK teenagers to trial social media bans, digital curfews
-
World champions England still 'unfinished' ahead of Six Nations, says Mitchell
-
Rybakina outlasts Pegula to reach Miami Open semis
-
Barca build huge lead on Real Madrid in Women's Champions League quarters
-
Alleged Rihanna mansion shooter pleads not guilty
-
US jury finds Meta, YouTube liable in social media addiction trial
-
US says Iran talks continue, will 'unleash hell' if no deal
-
UN designates African slave trade as 'gravest crime against humanity'
-
Trump's Beijing trip rescheduled for May, after Iran delay
-
No more excuses: World Cup pressure is on for host USA
-
US EPA issues waiver for E15 fuel to address oil supply issues
-
Grieving families hail court victory against Instagram, YouTube
-
Internet providers not liable for music piracy by users: top US court
-
Gaza civil defence says Israeli strike kills one, tents on fire
-
UK govt denies cover-up after PM ex-aide's phone stolen
-
California jury finds Meta, YouTube liable in social media addiction trial
-
Oil prices slip, stocks rally on Mideast peace hopes
-
South Africa police clash with anti-immigrant protesters
-
Gattuso says Italy's World Cup play-off 'biggest match' of career
-
Sakamoto leads skating swansong with 'Time to Say Goodbye' at worlds
-
Spanish PM says Middle East war 'far worse' than Iraq in 2003
-
First Robot: Melania Trump brings droid to White House event
-
Oldest dog DNA suggests 16,000 years of human companionship
-
Iran media casts doubt on US peace plan
-
Rare mountain gorilla twins born in DR Congo: park authorities
-
Ex-midwife enthroned as first female Archbishop of Canterbury
-
AC Schnitzer: When Iconic Tuners Fall Silent
-
Senegal lodge appeal to Court of Arbitration for Sport over AFCON final decision
-
South Africa seal T20 series win in New Zealand
-
Study links major polluters to big climate damages bill
-
Ex-Google chief Matt Brittin made new BBC director-general
-
Iran likely behind attacks sowing fear among Europe's Jews: experts
-
'Relieved' McGrath claims career first crystal globe in slalom
-
US ski star Shiffrin wins overall World Cup title for sixth time
-
Trump names tech titans to science advisory council
-
Mideast war sparks long queues at Kinshasa petrol stations
-
US TV star details 'agony' over mother's disappearance
-
Tehran receives US plan to end Mideast war, as Iran fires at US carrier
-
Aviation, tourism, agriculture... the economic sectors hit by the war
-
Iran fires at US carrier as backchannel diplomacy aims to end war
What is microRNA? Nobel-winning discovery explained
The Nobel Prize in Medicine was awarded on Monday to two US scientists for discovering microRNA, a previously unknown type of genetic switch which is hoped can pave the way for new medical breakthroughs.
But while several treatments and tests are under development using microRNAs against cancer, heart disease, viruses and other illnesses, none have actually yet reached patients.
And the world paid little attention when the new Nobel laureates Victor Ambros and Gary Ruvkun revealed their discovery decades ago, thinking it was just "something weird about worms", Cambridge University geneticist Eric Miska told AFP.
Here is an explainer about how exactly these tiny genetic switches work inside our bodies.
- What is microRNA? -
Each cell in the human body has the same set of instructions, called DNA. Some turn into brain cells, while others become muscles.
So how do the cells know what to become? The relevant part of the DNA's instructions is pointed to via a process called gene regulation.
Ribonucleic acid (RNA) normally serves as a messenger. It delivers the instructions from the DNA to proteins, which are the building blocks of life that turn cells into brains -- or muscles.
Miska gave the example of the messenger RNA vaccines rolled out against Covid-19 during the pandemic, which insert a message with new instructions to build proteins that block viruses.
But the two new Nobel winners Ambros and Ruvkun discovered a whole new type of gene regulator that had previously been overlooked by science.
Rather than being the messenger which relays information, microRNA instead acts as a switch to turn other genes off and on.
"This was a whole new level of control that we had totally missed," said Miska, who has worked on microRNA for two decades, including with the new Nobel laureates.
"The discovery of microRNAs brought an additional level of complexity by revealing that regions that were thought to be non-coding play a role in gene regulation," French researcher Benoit Ballester told AFP.
- What did the Nobel winners do? -
Back in the 1980s, Ambros and Ruvkun had been working separately on how genes interact in one-millimetre-long roundworms called C.elegans.
When they compared their work, it led to the discovery of microRNA. Ambros revealed the finding in a 1993 paper.
"Nobody really paid much attention," Miska said, explaining that most scientists at the time thought it only applied to worms.
Then in 2000, Ruvkun published research showing that microRNA is present right across the animal kingdom, including in humans and even some viruses.
"This was not just something weird that worms do, but in fact all animals and plants are totally dependent for development and normal function on them," Miska said.
More than a thousand genes that respond to microRNAs are now believed to be in the human body.
- How could this help us? -
There are numerous new treatments and tests using microRNA that are undergoing trials but none have been made widely available.
"Though there are no very clear applications available yet in microRNAs, understanding them, knowing that they exist, understanding their counter-regulatory networks, is always the first step," the Karolinska Institute's Gunilla Karlsson Hedestam told journalists in Stockholm.
MicroRNAs are particularly promising for fighting cancer because some of these switches "act as a tumour suppressor, so they put a brake on cells dividing inappropriately," Miska said.
Others, meanwhile, induce "cells to divide, which can lead to cancer", he added.
Because many viruses use microRNAs, several antiviral drugs are at varying stages of development, including for hepatitis C.
One complicating factor has been that microRNAs can be unstable.
But scientists also hope they can be used as a test called a "biomarker", which could reveal what type of cancer a patient could be suffering from, for example.
- What next? -
It also appears probable that microRNAs could be involved in the evolution of our species, Miska said.
While human brains are difficult to study, Miska hoped future research will discover more.
G.AbuOdeh--SF-PST